Mydecine Innovations Group Inc. (MYCOF)
OTCMKTS · Delayed Price · Currency is USD
0.0065
+0.0010 (18.25%)
At close: Aug 1, 2025
MYCOF Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
400.18K USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 7.49K | 4.88K | 186.32% |
| Dec 31, 2020 | 2.62K | -122.96K | -97.92% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 84.04M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.70M |
Mydecine Innovations Group News
- 5 weeks ago - Mydecine Innovations Group Provides Update On Annual Financial Statements - TheNewswire
- 7 weeks ago - Mydecine Innovations Group Provides Update on Annual Financial Statements - TheNewswire
- 2 months ago - Mydecine Innovations Group Provides Update on Annual Financial Statements - TheNewswire
- 2 months ago - Mydecine Innovations Group Provides Update on Annual Financial Statements - TheNewswire
- 3 months ago - Mydecine Innovations Group Announces Late Filing Of Annual Financial Statements And Management Cease Trade Order - TheNewswire
- 4 months ago - Mydecine Innovations Group Announces Changes To Board And Management - TheNewswire
- 1 year ago - Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds - GlobeNewsWire
- 1 year ago - Mydecine Innovations Group Announces Director Resignation - GlobeNewsWire